LT5379B - Reguliuojamo atpalaidavimo betahistino kompozicijos - Google Patents

Reguliuojamo atpalaidavimo betahistino kompozicijos Download PDF

Info

Publication number
LT5379B
LT5379B LT2006009A LT2006009A LT5379B LT 5379 B LT5379 B LT 5379B LT 2006009 A LT2006009 A LT 2006009A LT 2006009 A LT2006009 A LT 2006009A LT 5379 B LT5379 B LT 5379B
Authority
LT
Lithuania
Prior art keywords
tablets according
betahistine
coating
tablet
hydrophilic
Prior art date
Application number
LT2006009A
Other languages
English (en)
Lithuanian (lt)
Other versions
LT2006009A (en
Inventor
Flavio Fossati
Anna Perachiotti
Marco Carnaghi
Luciano Marcelloni
Original Assignee
Farmaceutici Formenti S. P. A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmaceutici Formenti S. P. A. filed Critical Farmaceutici Formenti S. P. A.
Publication of LT2006009A publication Critical patent/LT2006009A/xx
Publication of LT5379B publication Critical patent/LT5379B/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LT2006009A 2003-07-04 2006-02-01 Reguliuojamo atpalaidavimo betahistino kompozicijos LT5379B (lt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03015172A EP1493435B1 (en) 2003-07-04 2003-07-04 Controlled Release Compositions of Betahistine

Publications (2)

Publication Number Publication Date
LT2006009A LT2006009A (en) 2006-06-27
LT5379B true LT5379B (lt) 2006-10-25

Family

ID=33427119

Family Applications (1)

Application Number Title Priority Date Filing Date
LT2006009A LT5379B (lt) 2003-07-04 2006-02-01 Reguliuojamo atpalaidavimo betahistino kompozicijos

Country Status (17)

Country Link
EP (1) EP1493435B1 (pt)
CN (1) CN1816323A (pt)
AT (1) ATE395048T1 (pt)
CY (1) CY1108551T1 (pt)
DE (1) DE60320965D1 (pt)
DK (1) DK1493435T3 (pt)
EA (1) EA011569B1 (pt)
EC (1) ECSP066267A (pt)
ES (1) ES2306827T3 (pt)
GE (1) GEP20084349B (pt)
LT (1) LT5379B (pt)
MX (1) MXPA06000090A (pt)
PL (1) PL379374A1 (pt)
PT (1) PT1493435E (pt)
SI (1) SI1493435T1 (pt)
TN (1) TNSN05326A1 (pt)
WO (1) WO2005004850A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2112920B1 (en) 2003-06-26 2018-07-25 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
AU2009253739B2 (en) 2008-05-27 2014-02-06 Otolanum Ag Methods of treating mammals with eustachian tube dysfunctions
DE102012105528A1 (de) * 2012-06-25 2014-01-02 Hennig Arzneimittel Gmbh & Co. Kg Arzneiform zur Freisetzung von Wirkstoffen
WO2015053620A1 (en) * 2013-10-07 2015-04-16 Disphar International B.V. Betahistine composition
DK3431078T3 (da) 2017-07-20 2021-04-19 Intas Pharmaceuticals Ltd Orale faste betahistinsammensætninger med ikkepulserende forlænget frigivelse
CN111249237A (zh) * 2019-12-21 2020-06-09 乐普恒久远药业有限公司 盐酸倍他司汀药物及其制备方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0016890A1 (fr) 1977-07-22 1980-10-15 Jean Sadia Cherqui Nouvelle forme galénique d'administration de la bêtahistine
EP0397025A1 (en) 1989-05-08 1990-11-14 PRODOTTI FORMENTI S.r.l. [2-(2-pyridyl)ethyl]-methylamine salts
EP0502642A1 (en) 1991-03-07 1992-09-09 Reckitt And Colman Products Limited Sustained release compositions
EP1158963A1 (en) 1999-03-05 2001-12-05 FARMACEUTICI FORMENTI S.p.A. Controlled-release compositions of betahistine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2432313A1 (fr) * 1978-08-01 1980-02-29 Foulhoux Pierre Nouvelle forme galenique de la betahistine et son procede d'obtention
GB2280604B (en) * 1993-07-02 1997-04-30 Resource Medical Limited Processing of active agents

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0016890A1 (fr) 1977-07-22 1980-10-15 Jean Sadia Cherqui Nouvelle forme galénique d'administration de la bêtahistine
EP0397025A1 (en) 1989-05-08 1990-11-14 PRODOTTI FORMENTI S.r.l. [2-(2-pyridyl)ethyl]-methylamine salts
IT1229237B (it) 1989-05-08 1991-07-26 Prodotti Formenti Sali di (2-(piridil)etil) metilammina
EP0502642A1 (en) 1991-03-07 1992-09-09 Reckitt And Colman Products Limited Sustained release compositions
EP1158963A1 (en) 1999-03-05 2001-12-05 FARMACEUTICI FORMENTI S.p.A. Controlled-release compositions of betahistine

Also Published As

Publication number Publication date
GEP20084349B (en) 2008-04-10
LT2006009A (en) 2006-06-27
EP1493435A1 (en) 2005-01-05
WO2005004850A1 (en) 2005-01-20
TNSN05326A1 (en) 2007-07-10
CN1816323A (zh) 2006-08-09
MXPA06000090A (es) 2006-04-07
EA011569B1 (ru) 2009-04-28
EP1493435B1 (en) 2008-05-14
DK1493435T3 (da) 2008-09-08
PL379374A1 (pl) 2006-09-04
EA200501908A1 (ru) 2006-08-25
ECSP066267A (es) 2006-07-28
DE60320965D1 (de) 2008-06-26
SI1493435T1 (sl) 2008-10-31
PT1493435E (pt) 2008-08-14
ATE395048T1 (de) 2008-05-15
CY1108551T1 (el) 2014-04-09
ES2306827T3 (es) 2008-11-16

Similar Documents

Publication Publication Date Title
LT5379B (lt) Reguliuojamo atpalaidavimo betahistino kompozicijos
RU2401125C2 (ru) Способ стабилизации лекарственного средства против деменции
UA62930C2 (uk) Швидкорозчинна таблетка, яка вміщує галантамінову сіль бромоводневої кислоти та спосіб її виготовлення
US20060039968A1 (en) Gabapentin tablets and method for their preparation
ZA200602497B (en) Pharmaceutical compositions of moxifloxacin and processes for their preparation
CA2651138C (en) Pharmaceutical composition
US20030044462A1 (en) Sustained release tablets containing bupropion hydrochloride
WO2016136849A1 (ja) 固形製剤
KR20190059868A (ko) 바레니클린 살리실레이트를 함유하는 서방성 제제 및 이의 제조 방법
CA2502582C (en) Pharmaceutical formulation of olanzapine
US20080221079A1 (en) Pharmaceutical composition of quetiapine fumarate
KR100708533B1 (ko) 안정성이 향상된 암로디핀 말레에이트의 약학 조성물
US20060204571A1 (en) Stable compositions of bupropion or its pharmaceutically acceptable salts
WO2007134845A2 (en) Olanzapine pharmaceutical composition
US20120178810A1 (en) Extended release formulation of an antiepileptic agent
US20120058185A1 (en) Stable pharmaceutical compositions of olanzapine and process for their preparation
EA011579B1 (ru) Композиция с пролонгированным высвобождением венлафаксина
EP3727344A1 (en) Fixed dosed pharmaceutical compositions comprising amlodipine, ramipril and atorvastatin
KR102444073B1 (ko) 안정성이 향상된 메틸에르고메트린말레산염 함유 약제학적 제제 및 이의 제조방법
JP2002087963A (ja) 直接打錠により製造されたエピナスチン含有錠剤
WO2004045584A1 (en) Bupropion hydrochloride solid dosage forms
WO2005020978A1 (en) Sustained release oral tablets of gabapentin and process for their preparation
WO2024052820A1 (en) Upadacitinib formulation
GB2569616A (en) Sustained release oral pharmaceutical compositions of dicycloverine
WO2023128902A1 (en) Pharmaceutical compositions comprising bosentan and relevant excipients

Legal Events

Date Code Title Description
MM9A Lapsed patents

Effective date: 20110616